Lubaton, Joylyn .
HRN: 27-65-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2025
CEFUROXIME 500MG (TAB)
09/28/2025
10/04/2025
PO
500mg
1 Tab BID X 7 Days
Prophylaxis
Checking Initial Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines